Fluticasone Propionate Aerosol, Metered
Product Images NDC 50090-6058

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 50090-6058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)

Chemical structure of fluticasone propionate showing its molecular configuration with multiple rings, fluorine atoms, and ester groups as typical for this corticosteroid compound.*

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)

A line graph showing percent change from baseline in FEV1 over 12 weeks and at an endpoint. It compares two groups: placebo and Fluticasone Propionate HFA 88 mcg twice daily. The Fluticasone group shows a higher increase in FEV1 percentage over time compared to placebo.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)

A line graph showing the percentage change from baseline in FEV1 over 12 weeks for fluticasone propionate HFA at doses of 88 mcg, 220 mcg, and 440 mcg twice daily, compared to placebo. The graph plots weekly data points and includes an endpoint, illustrating dose-related increases in FEV1 with higher doses showing greater improvement than placebo.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)

A bar chart showing the percentage of subjects with 100% reduction in dose and percentage with an increase in dose for placebo and two dosages of Fluticasone Propionate HFA (440 mcg twice daily and 880 mcg twice daily). The chart compares placebo, 440 mcg twice daily, and 880 mcg twice daily groups on these outcomes.*

FDA Label Image

Figure A (Fluticasonepropionatehfa Spl Graphic 05)

An instructional illustration of a metered-dose inhaler showing labeled parts: metal canister, dark orange plastic actuator, dark orange mouthpiece, a counter display, and a separate peach-colored protective cap.*

FDA Label Image

Figure B (Fluticasonepropionatehfa Spl Graphic 06)

An instructional illustration showing a person holding a metered dose inhaler with one hand and the protective cap with the other hand, with an arrow indicating the removal of the cap from the inhaler mouthpiece.*

FDA Label Image

Figure C (Fluticasonepropionatehfa Spl Graphic 07)

An instructional illustration showing the proper use of a metered dose inhaler. It depicts a person holding the inhaler upright, pressing down on the canister to spray the medication while inhaling through the mouthpiece.*

FDA Label Image

Figure D (Fluticasonepropionatehfa Spl Graphic 08)

An instructional line drawing showing a hand holding and pressing down on a Fluticasone Propionate HFA metered-dose inhaler aerosol device. The image illustrates the proper technique to use the inhaler for respiratory administration.*

FDA Label Image

Figure E (Fluticasonepropionatehfa Spl Graphic 09)

An instructional illustration showing the 'Mouthpiece-Down position' for using an inhaler with a dark orange mouthpiece and a peach-colored cap, demonstrating correct hand placement on the device.*

FDA Label Image

Figure F (Fluticasonepropionatehfa Spl Graphic 10)

An instructional illustration showing a person exhaling with the instruction text 'Breathe out as much air as you can.' Arrows indicate the direction of air exiting the mouth during exhalation.*

FDA Label Image

Figure G (Fluticasonepropionatehfa Spl Graphic 11)

An instructional illustration showing a person using a metered-dose inhaler. The diagram includes the text 'Push down and breathe in' with an arrow indicating the action of pressing the inhaler while inhaling the medication through the mouth.*

FDA Label Image

Figure H (Fluticasonepropionatehfa Spl Graphic 12)

An instructional illustration showing a person rinsing their mouth over a sink with water in a glass nearby. The image emphasizes mouth rinsing, likely related to the use of an inhalation aerosol medication.*

FDA Label Image

Figure I (Fluticasonepropionatehfa Spl Graphic 13)

An instructional illustration showing two scenarios of inhaler use labeled 'Not blocked' and 'Blocked.' The 'Not blocked' image depicts proper airflow from the inhaler, while the 'Blocked' image shows obstruction with airflow restriction. The diagram visually guides correct inhaler technique for Fluticasone Propionate HFA aerosol metered inhalation.*

FDA Label Image

Figure J (Fluticasonepropionatehfa Spl Graphic 14)

An instructional diagram showing a close-up of a hand inserting a cartridge into the inhaler device of Fluticasone Propionate HFA aerosol. The image demonstrates twisting or locking the cartridge into place as part of assembly or preparation for use.*

FDA Label Image

Label Image (Lbl500906058)

Fluticasone Propionate HFA inhalation aerosol, 110 mcg strength, metered dose. The label displays the product name, dosage form as inhalation aerosol, and strength. It includes instructions to shake before use and store at room temperature between 68 to 77 degrees F, avoiding temperatures over 104 F. The label also states the bottle delivers 120 metered actuations and is offered by A-S Medication Solutions, Libertyville, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.